All filters
Abstracts
E-health for HIV service delivery in the context of the COVID-19 Pandemic
S. Emmanuel 
Presented at:
Workshop on Healthy Living with HIV 2020
Abstracts
Women above 50 navigating life with new HIV diagnosis in rural South Africa: a phenomenological study.
B.Mathabela 
Presented at:
Workshop on Healthy Living with HIV 2020
Slidesets
MTCT - Daniele De Luca
Presented at:
International Workshop on HIV Pediatrics 2020
Slidesets
SARS-Cov-2 Vaccines - Anthony Fauci
Presented at:
International Workshop on HIV Pediatrics 2020
Slidesets
Clinical Illness Including MIS-C - Elizabeth Whittaker
Presented at:
International Workshop on HIV Pediatrics 2020
Slidesets
School/Daycare - Moherndran Archary
Presented at:
International Workshop on HIV Pediatrics 2020
Slidesets
Susceptibility and Ability to Transmit - Lynne Mofenson
Presented at:
International Workshop on HIV Pediatrics 2020
Slidesets
Prevention of Mother To Child HIV Transmission - Global Gaps and Potential Solutions - Benjamin Chi
Presented at:
International Workshop on HIV Pediatrics 2020
Slidesets
PrEP in Pregnancy and Breastfeeding: the Why, What and How - Jillian Pintye
Presented at:
International Workshop on HIV Pediatrics 2020
Slidesets
The "Why, When and How To" of HIV Disclosure: Perspectives from the North and South - Ann Petru
Presented at:
International Workshop on HIV Pediatrics 2020
Slidesets
Is U=U Applicable to Breastfeeding? - Lynne Mofenson
Presented at:
International Workshop on HIV Pediatrics 2020
Slidesets
Advances in Cure Research Across the Lifespan - Dan Kuritzkes
Presented at:
International Workshop on HIV Pediatrics 2020
Slidesets
The HIV Epidemic in Infants, Children, Adolescents and Women Today - 2020 UNAIDS Update - Mary Mahy
Presented at:
International Workshop on HIV Pediatrics 2020
Slidesets
HIV and COVID-19 in Children, Double Trouble - Martina Penazzato
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Twenty-four week safety, tolerability and efficacy of dolutegravir dispersible tablets in children 4 weeks to <6 years old with HIV: results from IMPAACT P1093
T. Ruel Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Pediatric dolutegravir (DTG) dosing recommendations derived from combined P1093 and ODYSSEY Population Pharmacokinetic analysis
R. Singh Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Safety, pharmacokinetics, and efficacy of low-dose E/C/F/TAF in virologically suppressed children ≥2 years old living with HIV
E. Natukunda Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Safety, pharmacokinetics and acceptability of the ABC/3YC/LPV/R granules (4-in-1) in children living with HIV (3-20kg) in Uganda: LOLIPOP study
J. Mwanga-Amumpaire Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Acceptability of a new 4-in-1 Abacavir/Lamivudine/Lopinavir/Ritonavir paediatric fixed-dose combination: the caregiver-child dyads’ perspective
A. Rotsaert Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020